Suchergebnisse - (Subject:"Ritonavir")

PubPharm (9.302)

1

Proof-of-concept studies with a computationally designed Mpro inhibitor as a synergistic combination regimen alternative to Paxlovid

enthalten in: Proceedings of the National Academy of Sciences of the United States of America | 2024

von Papini, C. | Ullah, I. | Ranjan, A. | +11

2

A combination of nirmatrelvir and ombitasvir boosts inhibition of SARS-CoV-2 replication

enthalten in: Antiviral research | 2024

von Moon, C. | Porges, E. | Roberts, A. | +1

3

Physiologically-based pharmacokinetic modelling guided dose evaluations of nirmatrelvir/ritonavir in renal impairment for the management of COVID-19

enthalten in: British journal of clinical pharmacology | 2024

von Ng, T. | Wang, Z. | Chan, E.

4

Ritonavir : 25 Years' Experience of Concomitant Medication Management. A Narrative Review

enthalten in: Infectious diseases and therapy | 2024

von Quercia, R. | Di Perri, G. | Pein, C. | +4

5

Review : The Landscape of Antiviral Therapy for COVID-19 in the Era of Widespread Population Immunity and Omicron-Lineage Viruses

enthalten in: Clinical infectious diseases : an official publication of the Infectious Diseases Society of America | 2024

von Meyerowitz, E. | Li, Y.

6

Development of lipid-based SEDDS using digestion products of long-chain triglyceride for high drug solubility : Formulation and dispersion testing

enthalten in: International journal of pharmaceutics | 2024

von Desai, H. | T M Serajuddin, A.

7

Effectiveness of nirmatrelvir-ritonavir versus azvudine for adult inpatients with severe or critical COVID-19

enthalten in: BMJ open respiratory research | 2024

von Zhang, H. | Xiaojiao, T. | Chen, J. | +8

8

The effectiveness of novel oral antiviral treatment for non-hospitalized high-risk patients with COVID-19 during predominance of omicron XBB subvariants

enthalten in: Expert review of anti-infective therapy | 2024

von Hsu, C. | Hsu, W. | Shiau, B. | +6

9

Mild SARS-CoV-2 infection in vulnerable patients : implementation of a clinical pathway for early treatment

enthalten in: Enfermedades infecciosas y microbiologia clinica (English ed.) | 2024

von Pinargote-Celorio, H. | Otero-Rodríguez, S. | González-de-la-Aleja, P. | +11

10

Adverse events related to drug-drug interactions in COVID-19 patients. A persistent concern in the post-pandemic era : a systematic review

enthalten in: Expert opinion on drug metabolism & toxicology | 2024

von Conti, V. | Bertini, N. | Ricciardi, R. | +8

1
2
3
4
5
6
7
8
9
10
11
Nächster »
[931]